Compare · AMED vs NAKA
AMED vs NAKA
Side-by-side comparison of Amedisys Inc (AMED) and Nakamoto Inc. (NAKA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and NAKA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 51.6x NAKA ($81.4M).
- Over the past year, AMED is up 7.1% and NAKA is down 99.1% - AMED leads by 106.2 points.
- NAKA has hit the wire 8 times in the past 4 weeks while AMED has been quiet.
- AMED has more recent analyst coverage (25 ratings vs 3 for NAKA).
- Company
- Amedisys Inc
- Nakamoto Inc.
- Price
- $100.98-0.00%
- $4.67+8.74%
- Market cap
- $4.20B
- $81.4M
- 1M return
- +3.66%
- -35.32%
- 1Y return
- +7.08%
- -99.13%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 0
- 8
- Recent ratings
- 25
- 3
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest NAKA
- Amendment: SEC Form SCHEDULE 13D/A filed by Nakamoto Inc.
- Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock
- Chief Executive Officer Bailey David F bought $309,516 worth of shares (55,115 units at $5.62), increasing direct ownership by 2% to 3,175,476 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $683,112 worth of shares (136,333 units at $5.01), increasing direct ownership by 5% to 3,120,361 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Nakamoto Announces Expansion of Board of Directors
- Bitcoin for Corporations to Host the First Dedicated Institutional Bitcoin Symposium in New York City
- Following Stockholder Approval, Nakamoto Announces 1-for-40 Reverse Stock Split to be Effective on May 22, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Nakamoto Inc.
- Nakamoto Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits